In particular, the in vitro production of proinflammatory mediators, such as interleukin-6 (IL-6) and CCL2, was markedly downregulated by trabectedin in circulating monocytes, macrophages, and tumor-associated macrophages (TAM) from human tumors [9–11]. Here, IL6 is linked to neoplasm.